FIRSTMARK PREVENT Trademark

Trademark Overview

On Thursday, January 26, 2012, a trademark application was filed for FIRSTMARK PREVENT with the United States Patent and Trademark Office. The USPTO has given the FIRSTMARK PREVENT trademark a serial number of 85526555. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 6, 2019. This trademark is owned by GenWay Biotech, Inc.. The FIRSTMARK PREVENT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, providing biomarker profiling which can aid in determining patients' risk for most common diseases and infections; Medical testing for diagnostic or treatment purposes
firstmark prevent

General Information

Serial Number85526555
Word MarkFIRSTMARK PREVENT
Filing DateThursday, January 26, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 6, 2019
Registration Number4326730
Registration DateTuesday, April 30, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2013

Trademark Statements

Goods and ServicesMedical services, namely, providing biomarker profiling which can aid in determining patients' risk for most common diseases and infections; Medical testing for diagnostic or treatment purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 6, 2019
Primary Code044
First Use Anywhere DateTuesday, November 1, 2011
First Use In Commerce DateSaturday, November 12, 2011

Trademark Owner History

Party NameGenWay Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameGenWay Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameGenWay Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, December 6, 2019CANCELLED SEC. 8 (6-YR)
Monday, April 30, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 30, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, February 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 9, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 21, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 21, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 19, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, July 26, 2012NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Thursday, July 26, 2012CONTINUATION OF FINAL REFUSAL E-MAILED
Thursday, July 26, 2012ACTION CONTINUING A FINAL - COMPLETED
Thursday, July 26, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 26, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 16, 2012ASSIGNED TO LIE
Monday, July 9, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, July 2, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 2, 2012FINAL REFUSAL E-MAILED
Monday, July 2, 2012FINAL REFUSAL WRITTEN
Friday, June 15, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 14, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 14, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 7, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 7, 2012NON-FINAL ACTION E-MAILED
Monday, May 7, 2012NON-FINAL ACTION WRITTEN
Thursday, May 3, 2012ASSIGNED TO EXAMINER
Tuesday, January 31, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 30, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

prevent firstmark medical diseases common infections testing purposes treatment diagnostic most patients